Price
No data yet.
Social Signal Score
Analyst Ratings
17 analystsRevenue
$207.86M+91.51%Analyst Estimates
Consensus estimates, not results. Via Financial Modeling Prep.
Company Profile
- CEO
- Massimo Calafiore
- Sector
- Healthcare
- Industry
- Medical - Devices
- Employees
- 1,605
- Beta
- 0.64
- Country
- US
- Piotroski score
- 3 / 9 (Weak)
- Altman Z-score
- 0.99
Financials
Revenue
$207.86M+91.5%Net Income
$-6.07MEBITDA
$641.0K-95.3%Free Cash Flow
$-14.14M-731.8%EPS (diluted)
$-0.15Shares Outstanding (diluted)
41.18M+130.5%Operating Expenses
$140.61MCash & Debt
$86.32MReturn of Capital
$0.00Revenue by Segment (annual)
$687.65MQuote
Valuation & Ratios
Returns & Efficiency
Revenue & Net Income (Annual)
| Fiscal Year | Revenue | Net Income | EPS |
|---|---|---|---|
| 2025 | $822.31M | $-92.19M | $-2.28 |
| 2024 | $799.49M | $-126.00M | $-3.30 |
| 2023 | $746.64M | $-151.40M | $-4.12 |
| 2022 | $460.71M | $-19.75M | $-0.98 |
| 2021 | $464.48M | $-38.38M | $-1.95 |
| 2020 | $406.56M | $2.52M | $0.13 |
| 2019 | $459.95M | $-28.46M | $-1.51 |
| 2018 | $453.04M | $13.81M | $0.75 |
| 2017 | $433.82M | $6.22M | $0.34 |
| 2016 | $409.79M | $3.06M | $0.17 |
| 2015 | $396.49M | $-2.81M | $-0.15 |
| 2014 | $402.28M | $-8.54M | $-0.46 |
| 2013 | $400.53M | $-28.48M | $-1.52 |
| 2012 | $462.32M | $51.30M | $2.70 |
Valuation
OFIXhas no positive reported earnings per share, so an earnings-multiple projection can't be built for it. Companies are valued on other measures at this stage — revenue growth, cash burn, or book value — none of which this calculator models.
Signal Score (90d)
77+53.33%Social Signal Score
Mentions (6)
- Newszacks.com·4d ago·Positive
Orthofix (OFIX) Upgraded to Buy: What Does It Mean for the Stock? Orthofix (OFIX) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
View source ↗ - Newsmarketbeat.com·13d ago·Negative
Orthofix Medical Q3 Earnings Call Highlights Orthofix Medical NASDAQ: OFIX lowered its 2026 outlook after third-quarter results fell short of management's expectations, as softer U.S. spine procedure volumes and supplier delays constrained its ability to support demand.
View source ↗ - Newsseekingalpha.com·13d ago·Positive
Orthofix Medical Inc. (OFIX) Q3 2026 Earnings Call Transcript Orthofix Medical Inc. (OFIX) Q3 2026 Earnings Call Transcript
View source ↗ - Newszacks.com·17d ago·Positive
Orthofix (OFIX) Surges 11.0%: Is This an Indication of Further Gains? Orthofix (OFIX) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.
View source ↗ - Newsbusinesswire.com·30d ago·Neutral
Orthofix to Report Third Quarter 2026 Financial Results LEWISVILLE, Texas--(BUSINESS WIRE)--Orthofix Medical Inc. (NASDAQ:OFIX), a leading global medical technology company, today announced that it will release its third quarter 2026 financial results on Monday, November 9, 2026, before market open. The Company will host a conference call and webcast to review results at 8:30 am Eastern Time the same day. Interested parties may access the conference call by dialing 833-461-5787 in the U.S., and …
View source ↗ - Newsmarketbeat.com·99d ago·Neutral
Orthofix Medical Sees Reimbursement Rebound, but Spine Slump Clouds Outlook Orthofix Medical NASDAQ: OFIX executives said the company's updated outlook reflects the restoration of bone growth stimulation reimbursement, improving trends in biologics and limb reconstruction, and an expected European inventory order, partly offset by a steeper-than-anticipated decline among smaller U.S. spine distributors.
View source ↗
Earnings
Tue, Feb 23(in 3 months)
Consensus estimate $-0.07 per share
Typical surprise +18.2% (median, so one quarter with a near-zero estimate can't distort it)
- Mon, Nov 9$-0.15 vs $-0.27beat
- Wed, Aug 5$-0.39 vs $-0.41beat
- Tue, May 5$-0.52 vs $-0.68beat
- Tue, Feb 24$-0.06 vs $-0.19beat
- Tue, Nov 4$-0.57 vs $0.12miss
- Tue, Aug 5$-0.36 vs $-0.44beat
Estimates and results for OFIX via Financial Modeling Prep. Beating consensus says the company cleared the bar analysts set, not that the business grew.
Insider trading
Open-market buys and sells by OFIX officers and directors.
- Bought
- $13.4m
- Sold
- $6.7m
28 trades
33 trades
- Juniper Investment Company, Llcbought
- Juniper Investment Company, Llcbought
- Fisher Patricksold
- Fisher Patricksold
- Juniper Investment Company, Llcbought
- Juniper Investment Company, Llcsold
- Juniper Investment Company, Llcbought
- Juniper Investment Company, Llcsold
39 further Form 4 entries are share awards, option exercises or shares withheld for tax. Those are compensation, not trades, so they are excluded above. Buying is the stronger signal: an insider spends their own money for one reason. Selling has many innocent explanations — tax, diversifying, a house — so it says far less than it appears to. Via SEC filings.
Congress trades
No disclosed congressional trades in OFIX.
Self-reported filings, amounts as brackets. Via Senate/House disclosures.
